Replimune (REPL) Assets Average (2018 - 2026)

Replimune (REPL) reported Assets Average of $333.0 million for Q1 2026, down 42.34% on a YoY basis from $577.5 million in Q1 2025, and down 7.89% sequentially from $361.5 million in Q4 2025.

Replimune (REPL) Assets Average (2018 - 2026) Analysis & Trends

Replimune (REPL) has 9 years of Assets Average data on file, last reported at $333.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average fell 42.34% year-over-year to $333.0 million; the trailing twelve-month figure through Mar 2026 stood at $333.0 million (down 42.34% YoY), and the FY2026 full-year result was $441.9 million, down 14.95% from the prior year.
  • Assets Average retreated to $333.0 million in Q1 2026, from $361.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $662.6 million in Q1 2023 to a low of $333.0 million in Q1 2026.
  • A 5-year average of $509.3 million and a median of $511.3 million in 2024 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average soared 40.01% in 2023 and slumped 42.34% in 2026, its largest moves.
  • Tracing REPL's Assets Average over 5 years: stood at $557.3 million in 2022, then retreated by 1.73% to $547.7 million in 2023, then grew by 0.59% to $550.9 million in 2024, then slumped by 34.38% to $361.5 million in 2025, then dropped by 7.89% to $333.0 million in 2026.
  • Business Quant data shows REPL's Assets Average at $333.0 million in Q1 2026, $361.5 million in Q4 2025, and $429.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Replimune 970.73 Mn 970.73 Mn - 332.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 332.99 Mn
Dec 31, 2025 361.52 Mn
Sep 30, 2025 429.48 Mn
Jun 30, 2025 510.42 Mn
Mar 31, 2025 577.48 Mn
Dec 31, 2024 550.92 Mn
Sep 30, 2024 516.58 Mn
Jun 30, 2024 511.34 Mn
Mar 31, 2024 510.33 Mn
Dec 31, 2023 547.66 Mn
Sep 30, 2023 583.14 Mn
Jun 30, 2023 625.24 Mn
Mar 31, 2023 662.57 Mn
Dec 31, 2022 557.32 Mn
Sep 30, 2022 447.76 Mn
Jun 30, 2022 460.31 Mn
Mar 31, 2022 473.24 Mn
Dec 31, 2021 494.37 Mn
Sep 30, 2021 513.59 Mn
Jun 30, 2021 533.41 Mn